Dave Helsel - Net Worth and Insider Trading
Dave Helsel Net Worth
The estimated net worth of Dave Helsel is at least $638,575 dollars as of 2024-10-10. Dave Helsel is the EVP, Global Manufacturing of Haemonetics Corp and owns about 6,856 shares of Haemonetics Corp (HAE) stock worth over $521,810. Dave Helsel is also the SVP Global Operations and R&D of AngioDynamics Inc and owns about 19,189 shares of AngioDynamics Inc (ANGO) stock worth over $116,765. Details can be seen in Dave Helsel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dave Helsel has not made any transactions after 2023-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dave Helsel
Dave Helsel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dave Helsel owns 2 companies in total, including AngioDynamics Inc (ANGO) , and Haemonetics Corp (HAE) .
Click here to see the complete history of Dave Helsel’s form 4 insider trades.
Insider Ownership Summary of Dave Helsel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANGO | AngioDynamics Inc | 2023-07-14 | SVP Global Operations and R&D |
| HAE | Haemonetics Corp | 2013-04-30 | VP & Global Manufacturing |
Dave Helsel Latest Holdings Summary
Dave Helsel currently owns a total of 2 stocks. Among these stocks, Dave Helsel owns 6,856 shares of Haemonetics Corp (HAE) as of April 30, 2013, with a value of $521,810 and a weighting of 81.71%. Dave Helsel also owns 19,189 shares of AngioDynamics Inc (ANGO) as of January 31, 2023, with a value of $116,765 and a weighting of 18.29%.
Latest Holdings of Dave Helsel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HAE | Haemonetics Corp | 2013-04-30 | 6,856 | 76.11 | 521,810 |
| ANGO | AngioDynamics Inc | 2023-01-31 | 19,189 | 6.09 | 116,765 |
Holding Weightings of Dave Helsel
Dave Helsel Form 4 Trading Tracker
According to the SEC Form 4 filings, Dave Helsel has made a total of 0 transactions in Haemonetics Corp (HAE) over the past 5 years. The most-recent trade in Haemonetics Corp is the acquisition of 272 shares on April 30, 2013, which cost Dave Helsel around $8,903.
According to the SEC Form 4 filings, Dave Helsel has made a total of 5 transactions in AngioDynamics Inc (ANGO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AngioDynamics Inc is the sale of 4,633 shares on January 31, 2023, which brought Dave Helsel around $59,997.
Insider Trading History of Dave Helsel
- 1
Dave Helsel Trading Performance
GuruFocus tracks the stock performance after each of Dave Helsel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dave Helsel is 5.87%. GuruFocus also compares Dave Helsel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dave Helsel within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dave Helsel's insider trading performs compared to the benchmark.
Performance of Dave Helsel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.21 | | | | | |
| Relative Return to S&P 500(%) | 2.83 | | | | | |
Dave Helsel Ownership Network
Dave Helsel Owned Company Details
What does AngioDynamics Inc do?
Who are the key executives at AngioDynamics Inc?
Dave Helsel is the SVP Global Operations and R&D of AngioDynamics Inc. Other key executives at AngioDynamics Inc include SVP and General Counsel Stephen A Trowbridge , director & President and CEO James C Clemmer , and SVP/GM & VIT Scott Centea .
AngioDynamics Inc (ANGO) Insider Trades Summary
Over the past 18 months, Dave Helsel made no insider transaction in AngioDynamics Inc (ANGO). Other recent insider transactions involving AngioDynamics Inc (ANGO) include a net purchase of 30,000 shares made by James C Clemmer , and a net purchase of 1,700 shares made by Stephen A Trowbridge .
In summary, during the past 3 months, insiders sold 0 shares of AngioDynamics Inc (ANGO) in total and bought 21,700 shares, with a net purchase of 21,700 shares. During the past 18 months, 0 shares of AngioDynamics Inc (ANGO) were sold and 31,700 shares were bought by its insiders, resulting in a net purchase of 31,700 shares.
AngioDynamics Inc (ANGO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AngioDynamics Inc Insider Transactions
Dave Helsel Mailing Address
Above is the net worth, insider trading, and ownership report for Dave Helsel. You might contact Dave Helsel via mailing address: 400 Wood Road, Braintree Ma 02184.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
